January 2026 in “JPRAS Open” In this pilot study, PDLLA scalp microinjections showed improvement in physician-rated Global Aesthetic Improvement Scale scores over 12-24 weeks for 90% of patients with non-scarring alopecia, with no serious adverse events reported, although findings remain preliminary due to methodological limitations.
December 2025 in “International Journal for Fundamental and Interdisciplinary Research in Homoeopathy.” In this retrospective case series, researchers observed that a combined treatment protocol of homoeopathy, Xogen therapy, diet, and vitamin supplementation progressively reduced hair fall and improved hair density in five male patients with androgenic alopecia.
October 2025 in “JMIR Dermatology” This study observed that in a series of 28 patients with different types of alopecia, specific trichoscopic markers like exclamation-mark hairs and yellow dots helped distinguish alopecia areata from conditions like lichen planopilaris and discoid lupus erythematosus, which showed follicular ostia loss and white scarring.
June 2025 in “International Journal of Dermatology” In this case series conducted in Austrian dermatology clinics, tralokinumab was found to be a well-tolerated and effective long-term treatment for adults with moderate-to-severe atopic dermatitis, with improvements in eczema severity and symptom suppression maintained over up to three years.
June 2025 in “Clinical Cosmetic and Investigational Dermatology” This study found that FUE hair transplantation is a safe and effective method for improving the appearance of stable cicatricial alopecia in children, though larger studies are needed to confirm these results and assess long-term outcomes.
January 2025 in “Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)” Accurate diagnosis is crucial to distinguish alopecia areata incognita from androgenetic alopecia in men for proper treatment.
December 2024 in “PubMed” In a case-series study, researchers reported significant hair regrowth in Alopecia Areata patients after three months of treatment with a topical preparation called Freezia cream, which was developed by specialized medical professionals and approved by the Iraqi Ministry of Health.
November 2024 in “Journal of Cosmetic Dermatology” Regenerative medicine is effective and safe for treating vitiligo.
May 2024 in “British Journal of Community Nursing” In this case series, researchers reviewed 38 case studies involving Prontosan® products for chronic lower limb ulcers and found that the treatments significantly improved wound healing and various quality of life outcomes, such as reduced malodour and pain, better mobility, and enhanced social life.
This observational study reviewed thyroid eye disease patients treated with teprotumumab at one center, reporting common side effects like fatigue and dry eye symptoms, with serious adverse events including two cases of blood clots and one pulmonary embolism.
November 2023 in “The journal of investigative dermatology/Journal of investigative dermatology” In this case series, researchers reported on the clinical characteristics and treatment approaches for Frontal Fibrosing Alopecia in four cases, emphasizing the importance of early identification and intervention to manage this scarring hair loss disorder that primarily affects the frontal hairline and eyebrows.
September 2023 in “Journal of the American Academy of Dermatology” This retrospective study found that among 20 pediatric patients in Rochester, MN, tinea capitis due to Trichophyton violaceum/soudanense presented with diverse scalp and body symptoms and suggested terbinafine may be more effective than griseofulvin for treatment.
July 2023 in “Dermatology practical & conceptual” Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.
July 2023 in “GLOBAL JOURNAL FOR RESEARCH ANALYSIS” This study explored a new treatment approach using 20% TCA application with topical bimatoprost solution for managing alopecia areata of the eyebrows in cases where traditional treatments failed, offering a potential additional option for difficult cases.
January 2023 in “Medicines” This study reported that using micronized-gingival connective tissues appeared safe and showed initial efficacy for reconstructing peri-implant soft tissues, suggesting potential as an alternative to traditional grafting methods.
25 citations
,
October 2015 in “Dermatology” This study observed that dapsone may be effective for treating pustular psoriasis, as four out of five patients showed improvement after previously failing other treatments.
15 citations
,
February 2024 in “Journal of Dermatological Treatment” This study observed that dupilumab may promote hair regrowth in alopecia areata patients, achieving significant results in a majority of cases without reported adverse events.
9 citations
,
August 2016 in “Dermatology Online Journal” This study reports that acquired frictional alopecia of the lower legs, often caused by socks or footwear, is a non-scarring condition that may be more common than previously thought.
6 citations
,
January 2020 in “Dermatology” This study suggests that men under 40 who develop persistent sexual side effects and insomnia after using finasteride for alopecia may be at increased risk of suicide.
2 citations
,
May 2025 in “Journal of Clinical Medicine” This study reported that in a case series of three adolescents with alopecia areata and atopic dermatitis, treatment with 15 mg/day of upadacitinib led to rapid improvement in skin symptoms and significant hair regrowth over 12 months, with no severe adverse events observed.
1 citations
,
January 2024 in “Pediatric Endocrinology Diabetes and Metabolism” In this retrospective study of eight Saudi children with hereditary vitamin D resistant rickets, researchers observed that adjunctive cinacalcet appeared safe and showed initial promise in improving serum PTH levels, though further investigation is needed to confirm its efficacy.
1 citations
,
January 2018 in “Pediatric Dermatology” No results are reported in this piece; it is a correspondence comment on treating hidradenitis suppurativa in children with finasteride.
January 2026 in “British Journal of Clinical Pharmacology” In this study, reports from individuals using Serenoa repens indicated a possible post-Serenoa syndrome characterized by persistent sexual and neuropsychiatric symptoms, with causality assessed as 'probable' in 54% of cases, highlighting an underrecognized safety concern that warrants further investigation.
July 2025 in “International Journal of Trichology” This study reported six pediatric cases of temporal triangular alopecia and highlighted the use of trichoscopy to distinguish it by detecting a distinctive carpet of vellus hair, helping to differentiate TTA from other hair loss conditions.
January 2025 in “Journal of Dermatological Treatment” This study describes three cases of filler-induced alopecia with hair regrowth observed following treatments, emphasizing the importance of early intervention and understanding anatomical risks during cosmetic filler procedures.
This study utilized polarized light microscopy to examine hair shafts in ten children with rare genetic disorders, such as Netherton syndrome and ectodermal dysplasia, providing valuable diagnostic insights into hair thickness, composition, and structural irregularities associated with these conditions.
January 2023 in “Book of Abstracts” COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.
December 2021 in “Clinical and Experimental Dermatology” This article is a letter to the editor regarding the use of systemic minoxidil as maintenance treatment in alopecia areata and includes no study results.
April 2021 in “HIV & AIDS Review” This study reported that GA 0.1% spray led to only slight improvement in treating anogenital warts among HIV-positive patients over twelve weeks.
November 2019 in “BMC veterinary research” This study concluded that moderate to severe alopecia in Belgian Blue crossbred calves was due to malabsorption of dietary fat caused by a mixing error of milk replacer.